CA
NZ
UK
AU
IND
US
Palantir Technologies Inc. officer Shyam Sankar filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 84,680 shares of common stock with an aggregate market value of $14,295,677.60, to be executed through a Rule 10b5-1 plan.
Andrew Hardy, an officer of NXP Semiconductors N.V., filed a Form 144 notice of proposed sale of 1,643 shares of common stock on November 11, 2026, with the filing submitted to the SEC on November 12, 2026.
Director Maura Markus filed a Form 144 Notice of Proposed Sale of Securities with the SEC on November 12, 2026, disclosing a plan to sell 3,180 shares of Broadridge Financial Solutions, Inc. common stock acquired through a stock option exercise on November 11, 2026.
Fair Isaac & Co Inc officer and director William J. Lansing filed a Form 144 notice of proposed sale on November 12, 2026, covering 9,782 shares of common stock acquired through a stock option exercise on November 11, 2026.
Stephen Gerard Daly, a director and officer of MACOM Technology Solutions Holdings, filed a Form 144 on November 12, 2026, providing notice of a proposed sale of 59,939 shares of common stock, with the sale executed on November 11, 2026.
BETA Technologies, Inc. officer Sean Donovan filed a Form 144 notice of proposed sale of 6,684 shares of common stock, with the filing submitted on November 12, 2026, covering a sale executed on November 11, 2026.
AppFolio, Inc. officer Evan Pickering filed a Form 144 Notice of Proposed Sale of Securities on November 12, 2026, covering 464 shares of AppFolio common stock with an aggregate market value of $104,288.64, executed on November 11, 2026 through Morgan Stanley Smith Barney LLC.
Nicholas Pinchuk, a director and officer of Snap-on Incorporated, filed a Form 144 notice of proposed sale on November 11, 2026, covering 23,447 shares of Snap-on common stock acquired through the exercise of stock options on the same date.
Spire Global Inc director and officer Peter Platzer filed a Form 144 notice on November 12, 2026, proposing to sell 20,000 shares of common stock on the NYSE with an aggregate market value of $187,000.00.
Haemonetics Corp officer Maryanne Farris filed a Form 144 notice of proposed sale on November 12, 2026, covering 836 shares of Haemonetics common stock with an aggregate market value of $101,144.38.
Please wait processing your request...